Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineoplastics Toxicity”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Ended earlyNCT01783522
What this trial is testing

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Who this might be right for
Chemotherapeutic Agent ToxicityMultiple MyelomaPeripheral Neuropathy
Beth Faiman 9
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Not applicableUnknownNCT04572282
What this trial is testing

Mobile App for Symptoms Monitoring in Cancer Patients: a Pilot Study

Who this might be right for
CancerSymptoms and SignsQuality of Life+1 more
Associacao de Investigacao de Cuidados de Suporte em Oncologia 30
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Not applicableLooking for participantsNCT07511413
What this trial is testing

GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Rectal CancerLung Cancer
Fondazione del Piemonte per l'Oncologia 110
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Not applicableUnknownNCT06077123
What this trial is testing

Telemonitoring Platforms and Chemotherapy-Associated Toxicity

Who this might be right for
CancerChemotherapeutic Agent Toxicity
Universidad Nacional Andres Bello 80
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Not applicableActive Not RecruitingNCT07163286
What this trial is testing

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

Who this might be right for
Nutrition Aspect of CancerSarcopeniaChemotherapeutic Agent Toxicity
Çanakkale Onsekiz Mart University 200
Large-scale testing (Phase 3)Study completedNCT00775645
What this trial is testing

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityFatigue+2 more
SWOG Cancer Research Network 437
Post-approval studies (Phase 4)Looking for participantsNCT06183437
What this trial is testing

The STOP-MED CTRCD Trial

Who this might be right for
Heart FailureCardiotoxicityCardiac Toxicity+2 more
Dinesh Thavendiranathan 335
Not applicableEnded earlyNCT00728429
What this trial is testing

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Wake Forest University Health Sciences 1
Early research (Phase 1)WithdrawnNCT01562301
What this trial is testing

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Chemotherapeutic Agent ToxicityLung Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Large-scale testing (Phase 3)Study completedNCT00855309
What this trial is testing

Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia

Who this might be right for
Herpes Simplex
Wake Forest University Health Sciences 112
Large-scale testing (Phase 3)Ended earlyNCT00486213
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Who this might be right for
Dermatologic ComplicationsPalmar-plantar ErythrodysesthesiaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237920
What this trial is testing

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Who this might be right for
Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by Site+8 more
The Netherlands Cancer Institute 90
Testing effectiveness (Phase 2)Study completedNCT00771433
What this trial is testing

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeutropenia
Centre Francois Baclesse 120
Large-scale testing (Phase 3)Study completedNCT02311907
What this trial is testing

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityNeuropathyNeurotoxicity Syndrome+13 more
Alliance for Clinical Trials in Oncology 195
Next Page